These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16135954)

  • 21. [Interferon treatment for age-related macular degeneration].
    Loewenstein A; Rosenblatt I; Yassur I; Yassur Y
    Harefuah; 1997 Feb; 132(4):275-9. PubMed ID: 9153898
    [No Abstract]   [Full Text] [Related]  

  • 22. Ranibizumab (Lucentis) for macular degeneration.
    Med Lett Drugs Ther; 2006 Oct; 48(1246):85-6. PubMed ID: 17051134
    [No Abstract]   [Full Text] [Related]  

  • 23. Age related macular degeneration.
    Arnold J; Sarks S
    Clin Evid; 2002 Dec; (8):614-28. PubMed ID: 12603902
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
    Kirkpatrick JN; Dick AD; Forrester JV
    Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bevacizumab versus ranibizumab: a draw?].
    Souied EH; Cohen SY; Kodjikian L
    J Fr Ophtalmol; 2012 Feb; 35(2):79-81. PubMed ID: 22033297
    [No Abstract]   [Full Text] [Related]  

  • 26. An update on photodynamic therapy in age-related macular degeneration.
    Rechtman E; Ciulla TA; Criswell MH; Pollack A; Harris A
    Expert Opin Pharmacother; 2002 Jul; 3(7):931-8. PubMed ID: 12083992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon treatment of SRNV.
    Donahue SP; Wall M; Weingeist TA
    Ophthalmology; 1994 Apr; 101(4):624-5. PubMed ID: 8152753
    [No Abstract]   [Full Text] [Related]  

  • 28. Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals.
    Vinding T
    Acta Ophthalmol (Copenh); 1990 Apr; 68(2):162-7. PubMed ID: 2356703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a.
    Ross C; Engler CB; Sander B; Bendtzen K
    J Interferon Cytokine Res; 2002 Apr; 22(4):421-6. PubMed ID: 12034024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
    Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
    Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The growing importance of pharmacoeconomics: the case of age-related macular degeneration.
    Smith AF
    Br J Ophthalmol; 2010 Sep; 94(9):1116-7. PubMed ID: 20576774
    [No Abstract]   [Full Text] [Related]  

  • 32. Mediation proportion.
    Ditlevsen S; Keiding N; Christensen U; Damsgaard MT; Lynch J
    Epidemiology; 2005 Jul; 16(4):592. PubMed ID: 15951684
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
    Kertes PJ; Britton WA; Leonard BC
    Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
    [No Abstract]   [Full Text] [Related]  

  • 34. [Photodynamic therapy of senile macular degeneration].
    Naeser K
    Ugeskr Laeger; 2005 Apr; 167(14):1540-1; author reply 1541. PubMed ID: 15887755
    [No Abstract]   [Full Text] [Related]  

  • 35. [Improved therapeutic possibilities of age-related macular degeneration. The Danish Society of Ophthalmology].
    Hansen MH; Mortensen KK; Sjølie AK
    Ugeskr Laeger; 2003 Mar; 165(12):1249. PubMed ID: 12701299
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
    Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
    Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is it possible to treat age-related macular degeneration?].
    Immonen I
    Duodecim; 1995; 111(12):1083-5. PubMed ID: 9213541
    [No Abstract]   [Full Text] [Related]  

  • 38. Photodynamic therapy in age-related macular degeneration: missing information.
    Wenkstern A; Stokes J
    Age Ageing; 2003 May; 32(3):357-9. PubMed ID: 12720631
    [No Abstract]   [Full Text] [Related]  

  • 39. [Epidemiology and risk factors for age related macular degeneration].
    Starzycka M
    Klin Oczna; 1997; 99(4):271-5. PubMed ID: 9577122
    [No Abstract]   [Full Text] [Related]  

  • 40. [Management algorithm of age-related macular degeneration with aflibercept: Real-life application].
    Gualino V; Baillif S; Kodjikian L
    J Fr Ophtalmol; 2016 Dec; 39(10):872-879. PubMed ID: 27789040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.